Drawing for ANEMOCYTE

USPTO serial 79404747

ANEMOCYTE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ALI, STEPHANIE MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with ANEMOCYTE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian A. Tollefson

Brian A. Tollefson Devlin Law Firm LLC1526 Gilpin Ave.Wilmington, DE 19806United States

Goods and services

ClassDescriptionStatusFirst use
005Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; medicines for dental purposes; chemical preparations for pharmaceutical or medical purposes, namely for oncology and immuno-oncology, respiratory, infectious diseases, flu, covid, cardiovascular, dermatology, rare diseases, metabolic diseases; biological preparations for the treatment of cancer, respiratory diseases, infectious diseases, flu, covid, cardiovascular diseases, dermatology diseases, rare diseases, metabolic diseases; biological reagents for medical purposes; vaccines; nucleic acid sequences for medical and veterinary products; dietetic foods adapted for medical use; antibodies for medical purposes; dietary supplements; pharmaceutical preparations for treating diabetes; diagnostic preparations for medical purposes; Biolofical tissue cultures fo rmedical useACTIVE—
010Medical instruments for cutting tissue; Surgical apparatus and instruments for medical, dental or veterinary use; Medical devices for use in treating or cancer, respiratory diseases, infectious diseases, flu, covid, cardiovascular diseases, dermatology diseases, rare diseases, metabolic diseases; Electro-surgical motors being part of surgical and medical apparatus and instruments for use in general surgeryACTIVE—
042Research and development of vaccines and medicines; scientific and technological services Scientific and technological services, namely manufacturing, scientific research, innovation and development, process development, analysis, testing, storage, stability studies, regulatory support in the field of cell and gene therapies, DNA and RNA; Research and development services in the field of medical preparations; medical research laboratories; design and development of computer hardware and computer software; scientific research; research and development services of new pharmaceutical products.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 20, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 14, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 23, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 22, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 22, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 22, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 8, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 8, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 8, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 18, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 18, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 11, 2025GPNXNOTIFICATION PROCESSED BY IB—
Dec 3, 2025ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Nov 26, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 25, 2025OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 25, 2025PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Nov 1, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 9, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 9, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 9, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 29, 2024RFNTREFUSAL PROCESSED BY IB—
Dec 9, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 9, 2024RFRRREFUSAL PROCESSED BY MPU—
Nov 24, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 23, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2024DOCKASSIGNED TO EXAMINER—
Sep 20, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 20, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 19, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance